Literature DB >> 10731475

Sequential changes in plasma cytokine and endotoxin levels in cirrhotic patients with bacterial infection.

S S Wang1, F Y Lee, C C Chan, R H Lu, Y Chao, H C Lin, S L Wu, Y T Tsai, S D Lee.   

Abstract

To delineate the clinical roles of plasma cytokine or endotoxin levels in the natural course of infection in patients with decompensated cirrhosis, 66 cirrhotic patients were studied within a 1.5-year period. Plasma levels of tumour necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), IL-6, IL-8 and endotoxin were determined on days 1, 4 and 7 after admission when hospital infection was suspected and 4 months later. A total of 24 patients (36.4%) were proven to be infected during hospitalization (group A), while 42 others were not infected (group B). Fever occurred in a very high proportion (22/24) of group A patients. Baseline levels of TNF-alpha (37.7+/-15.2 compared with 8.7+/-1.2 pg/ml; P<0.01) and IL-6 (180.5+/-20.5 compared with 24.6+/-7.5 pg/ml; P<0.0001) were higher in group A patients, while IL-1beta, IL-8 and endotoxin levels were not significantly different between the two groups. For patients with hospital infection, IL-6 levels determined during the episode were significantly higher than baseline levels. Using IL-6 >80 pg/ml as a baseline cut-off level to diagnose bacterial infection, the sensitivity, specificity and accuracy were 87.5, 100 and 95.5% respectively. The one-year cumulative probability of mortality (61.1% compared with 23.7%; P<0.001) and of bacterial re-infection (72.2% compared with 18.4%; P<0.0001) was higher in group A than in group B. Plasma TNF-alpha and IL-6 levels determined at 4 months were not different between the two groups. In conclusion, fever or elevated plasma IL-6 levels in patients with decompensated cirrhosis calls for early antibiotic treatment to prevent life-threatening bacterial infection. Bacterial infection is likely to recur in those patients with increased IL-6 levels, while severe episodes of infection occur in patients with increased TNF-alpha levels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10731475

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  5 in total

1.  The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection.

Authors:  Huseyin Ataseven; Ibrahim Halil Bahcecioglu; Nalan Kuzu; Mehmet Yalniz; Selman Celebi; Ahmet Erensoy; Bilal Ustundag
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

2.  Vaccinating Adult Patients with Cirrhosis: Trends over a Decade in the United States.

Authors:  Abhijeet Waghray; Nisheet Waghray; Hicham Khallafi; K V Narayanan Menon
Journal:  Gastroenterol Res Pract       Date:  2016-04-30       Impact factor: 2.260

Review 3.  Serum interleukin-6 in the diagnosis of bacterial infection in cirrhotic patients: A meta-analysis.

Authors:  Yinlian Wu; Mingfang Wang; Yueyong Zhu; Su Lin
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

4.  The role of interleukin-6 in the early diagnosis of sepsis in premature infants.

Authors:  Mehrdad Mirzarahimi; Manouchehr Barak; Abdolkarim Eslami; Afsaneh Enteshari-Moghaddam
Journal:  Pediatr Rep       Date:  2017-10-06

5.  Quality of Care in Patients With Cirrhosis: Trends in Recommended Adult Vaccination Coverage.

Authors:  Eimad M Ahmmad; Lewis R Roberts
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2020-09-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.